Our focus is to treat diseases that cause severe pain and to bring to market non-addictive pain medications. We’re starting with Peripheral Artery Disease (PAD), a painful condition affecting over 8.5 million Americans.
As we work towards Phase 2b trials for our PAD treatment, we have another goal in mind. Treat diseases at the source and reduce the need for opioid prescriptions.
A world without pain is just over the horizon.
So is a new JanOne.
We’re launching our new website soon.
JanOne sees every day as an opportunity for fresh ideas to end the opioid epidemic, the worst drug crisis in our nation’s history.
As a NASDAQ-listed company, JanOne draws private-sector resources into this urgent fight. We seek innovative treatments—focusing on developing revolutionary, non-addictive drugs that kill pain, not people.
March is National Autoimmune Disease month and as we are fighting an “invisible epidemic”, it is a great time to bring awareness. Approximately 23.5 million Americans are affected across the country, according to the NIH.
Best wishes of good health and safety in the days and weeks ahead to all of followers, friends and family.
https://www.whitehouse.gov/articles/15-days-slow-spread/
